Page last updated: 2024-10-30

metformin and Hypophosphatemia

metformin has been researched along with Hypophosphatemia in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Hypophosphatemia: A condition of an abnormally low level of PHOSPHATES in the blood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsitsios, T1
Sotirakopoulos, N1
Armentzioiou, K1
Kalogiannidou, I1
Kolaggis, A1
Mavromatidis, K1

Other Studies

1 other study available for metformin and Hypophosphatemia

ArticleYear
Metformin induced severe hypophosphatemia in a patient on hemodialysis.
    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2010, Volume: 21, Issue:5

    Topics: Aged; Biomarkers; Diabetes Mellitus; Down-Regulation; Fatigue; Female; Humans; Hypoglycemic Agents;

2010